Literature DB >> 8113761

Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusion.

C C Pak1, M Krumbiegel, R Blumenthal.   

Abstract

The fusion kinetics with erythrocyte ghosts of two influenza A virus strains, A/Aichi/2/68 (X:31) and A/PR/8/34 (PR/8), were compared and correlated with the kinetics of haemagglutinin (HA) conformational change. Previously it had been shown that X:31 fuses with liposomes or erythrocytes at 4 degrees C, pH 5 after a lag time of 5 to 10 min whereas PR/8 displayed no fusion with liposomes at that temperature. We have confirmed the absence of cold fusion by PR/8 with erythrocyte ghosts. In contrast to X:31, PR/8 could not be committed to fuse at neutral pH and 37 degrees C by a preincubation at low pH and 4 degrees C. To examine whether the lack of commitment and cold fusion were due to a failure of PR/8 HA to undergo conformational changes at low temperature and pH, we analysed susceptibility of HA to proteinase K digestion, liposome binding to the virus, and immunoprecipitations of HA with conformation-specific antibodies. Although there was little binding of PR/8 to liposomes at 4 degrees C and pH 5, we did observe exposure of the fusion peptide. This study reveals a low temperature intermediate in membrane fusion exhibited by the HA of influenza virus strain PR/8, which involves low pH-induced conformational changes including exposure of the fusion peptide with little interaction of HA with the target membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113761     DOI: 10.1099/0022-1317-75-2-395

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Conformational intermediates and fusion activity of influenza virus hemagglutinin.

Authors:  T Korte; K Ludwig; F P Booy; R Blumenthal; A Herrmann
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Stochastic simulation of hemagglutinin-mediated fusion pore formation.

Authors:  S Schreiber; K Ludwig; A Herrmann; H G Holzhütter
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

4.  Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

Authors:  M J Edwards; N J Dimmock
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Membrane fusion mediated by coiled coils: a hypothesis.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

6.  pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.

Authors:  C Cianci; K L Yu; D D Dischino; W Harte; M Deshpande; G Luo; R J Colonno; N A Meanwell; M Krystal
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus.

Authors:  G Luo; A Torri; W E Harte; S Danetz; C Cianci; L Tiley; S Day; D Mullaney; K L Yu; C Ouellet; P Dextraze; N Meanwell; R Colonno; M Krystal
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion.

Authors:  Tanay M Desai; Mariana Marin; Caleb Mason; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

9.  Low-pH-induced fusion of Vero cells infected with Junin virus.

Authors:  V Castilla; S E Mersich
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Kinetics of the low pH-induced conformational changes and fusogenic activity of influenza hemagglutinin.

Authors:  M Krumbiegel; A Herrmann; R Blumenthal
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.